Zlatina Gospodinova
Publications by Zlatina Gospodinova
2 publications found • Active 2017-2021
2021
1 publicationIn vitro Antiproliferative Effects of Cotinus coggygria Scop. on human non-melanoma and melanoma skin cancer cells
Skin cancer is one of the most frequently diagnosed malignancies worldwide and its incidence constantly increases. The disease divides in two major subtypes: non-melanoma and melanoma skin cancer. The main drawbacks of the traditional skin cancer therapy are primary and acquired drug resistance and serious side effects due to the nonspecific treatments targeting. Despite advances in therapy strategies there is a need of new affordable natural anti-skin cancer agents, which to possess higher efficiency without causing detrimental side effects. Medicinal plants provide great possibility for the discovery of new anticancer therapeutics with preventive and treatment potential. Cotinus coggygria Scop. is a plant species widely applied in phytotherapy predominantly against disorders of the skin and mucosal tissues. The herb has a large range of valuable biological activities but its anticancer properties have not been thoroughly studied. The aim of the present research was to assess the antiproliferative properties of the crude leaf aqueous ethanolic extract from Bulgarian herb C. coggygria and its chloroformic and aqueous fractions on a panel of human skin cancer cell lines: basal cell carcinoma (TE 354.T), squamous cell carcinoma (A431) and malignant melanoma (A375) and to compare them to the cell growth inhibitory potential on normal dermal cell line (BJ). The antiproliferative capacity of the plant substances was investigated using MTT assay and microscopy cell morphology observation after 72 h cell treatment in a wide scale of concentrations. The obtained results showed that the crude extract and both fractions inhibit significant proliferation of A431 squamous cell carcinoma and A375 melanoma cells with the highest cytostatic effect registered for the aqueous fraction on A375 cells with a half maximal inhibitory concentration value of 44.33 ?g/ml. C. coggygria exhibited no cytostatic activity towards TE 354.T basal cell carcinoma cells. The established marked slighter reduction in the growth of normal BJ cell line in comparison to cancer A375 and A431 cells was indicative for a selectivity in the antiproliferative action. It could be concluded that medicinal plant C. coggygria possesses promising antiproliferative properties against A375 and A431 skin cancer cell lines which will be further investigated in details.
2017
1 publicationEffects of Cotinus Coggygria Extract on the Transcriptional Levels Of Histone Deacetylase Genes In Breast Cancer Cells In Vitro
Despite the significant progress in cancer treatment in recent years, the disease remains a leading cause of death worldwide. Histone deacetylases are a family of enzymes recognized as key regulators of the process of histone acetylation, a main epigenetic event involved in the control of gene transcription. High expression levels of histone deacetylases are distinctive for cancer cells and a searching for new more effective and less toxic histone deacetylase inhibitors with natural origin is a nowadays intensively studied research direction in cancer prevention and therapy. Cotinus coggygria is a medicinal plant possessing numerous valuable biological properties. The antitumor potential of C. coggygria extracts is poorly studied and the available data concerning the anticancer capacity of the Bulgarian herb are limited only to a previous research of the authors, which detected reduction in viability of breast cancer cell line MCF7 after treatment with aqueous ethanolic leaf extract. The objective of the present study was to evaluate the ability of C. coggygria extract to modify the process of histone acetylation by transcription analysis of nine genes coding for histone deacetylases after treatment of MCF7 cells for different time periods through quantitative Reverse Transcription - Polymerase Chain Reaction. The obtained results showed statistically significant reduction in the relative amount of HDAC5 and HDAC7 mRNA transcripts at 48 hour after treatment and a tendency of HDAC3 expression inhibition at 72 hour. Future investigations will be directed to assessment of the extract effect on the expression of genes coding histone acetyltransferases in MCF7 cells.
